Forum

× click the New Topic button to post

BCG non-responsive within 1 year - ALT-803

6 months 3 weeks ago #56969 by sara.anne
Sorry to hear that your cancer returned. Unfortunately, that is a nasty habit of bladder cancer. There is a lot of information about similar clinical trials available....Google:

Trial of Inravesical (BCG) in Combination with ALT-803 in Patients with High Grade Non-Muscle Invasive Bladder Cancer)

and you can see many on-going trials and some reports of finished ones. Of course, it would be hard to tell which one you might be thinking of joining,

Some questions I always ask when considering a clinical trial (and I have been on both sides...as a patients and as a part of the trial design):

Is the purpose of this trial to study effectiveness? (Sometimes...not in this case...the initial purpose is just to see if humans tolerate the substance)

Is this a blind trial? (for example, will half the patients receive JUST BCG and the other half BCG plus the study drug or will all the patients receive the study drug?)

How will I be followed after the trial ends?

What are the possible known side effects?

I am sure that you can think of other questions, but these are a start.

If you do join this trial, please keep us informed about how it goes. So many people never have the opportunity to be part of a good clinical trial and would be interested in following your adventure!

Sara Anne

Diagnosis 2-08 Small papillary TCC; CIS
BCG; BCG maintenance
Vice-President, American Bladder Cancer Society
Forum Moderator

Please Log in or Create an account to join the conversation.

6 months 3 weeks ago #56968 by Robair
Greetings,
I appreciate this site as last year it was my single best source for facing BCG treatments. They began in Feb and I did a maintenance round (3 instillations) in September.

Unfortunately for me the high grade cancer (non-invasive) returned and was confirmed in December. While waiting to have another round of BCG my doctor recommended that I discuss my eligibility for a study (Trial of Inravesical (BCG) in Combination with ALT-803 in Patients with High Grade Non-Muscle Invasive Bladder Cancer).

I have been able to see a study using this involving 9 participants. That is all I can find. Is anyone familiar with the study? I am scheduled to start 3/15 pending the outcome of a physical and CT scan tomorrow. Thanks in advance.

Please Log in or Create an account to join the conversation.

  • Not Allowed: to create new topic.
  • Not Allowed: to reply.
  • Not Allowed: to add Files.
  • Not Allowed: to edit your message.
Moderators: Cynthiaeddieksara.anne

Users

Total Online: 1 User and 1375 Guests 
eggie's Avatareggie

Legend: Site Administrator Global Moderator User Banned

Statistics

Today Total Opened: 3 Today Total Answered: 3 Latest User: eggie
Yesterday Total Opened: 1 Yesterday Total Answered: 4
Total Posts: 52635 Total Subjects: 6837 Total Users: 8400
Powered by Kunena Forum